Search results
Results from the WOW.Com Content Network
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland.It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases.
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $58.06, marking a -0.77% move from the previous day.
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $38.33, marking a -1.01% move from the previous day.
CRISPR Therapeutics AG (CRSP) closed at $54.33 in the latest trading session, marking a -0.93% move from the prior day.
The NYSE Composite outperformed the Dow Jones Industrial Average, the Nasdaq Composite, and the S&P 500 in 2004, 2005, and 2006 [3] and closed above the 10,000 level for the first time on June 1, 2007. The NYSE Composite set a closing high of 10,311.61 on October 31, 2007, but failed to pass the intra-day high of 10,387.17 it reached in trading ...
A corporation can adjust its stock price by a stock split, substituting a quantity of shares at one price for a different number of shares at an adjusted price where the value of shares x price remains equivalent. (For example, 500 shares at $32 may become 1000 shares at $16.) Many major firms like to keep their price in the $25 to $75 price range.
CRISPR Therapeutics AG (CRSP) closed at $76.50 in the latest trading session, marking a +0.9% move from the prior day.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.